Cargando…

The Impact of the Level of the Intestinal Short Chain Fatty Acids in Inflammatory Bowel Disease Patients Versus Healthy Subjects

The aim of this study was to determine the changes of short chain fatty acids (SCFAs) in faeces of inflammatory bowel disease (IBD) patients compared to healthy subjects. SCFAs such as pyruvic, lactic, formic, acetic, propionic, isobutyric and butyric acids were analyzed by using high performance li...

Descripción completa

Detalles Bibliográficos
Autores principales: Huda-Faujan, N., Abdulamir, A.S., Fatimah, A.B., Anas, O. Muhammad, Shuhaimi, M., Yazid, A.M., Loong, Y.Y.
Formato: Texto
Lenguaje:English
Publicado: Bentham Open 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2887640/
https://www.ncbi.nlm.nih.gov/pubmed/20563285
http://dx.doi.org/10.2174/1874091X01004010053
_version_ 1782182576111222784
author Huda-Faujan, N.
Abdulamir, A.S.
Fatimah, A.B.
Anas, O. Muhammad
Shuhaimi, M.
Yazid, A.M.
Loong, Y.Y.
author_facet Huda-Faujan, N.
Abdulamir, A.S.
Fatimah, A.B.
Anas, O. Muhammad
Shuhaimi, M.
Yazid, A.M.
Loong, Y.Y.
author_sort Huda-Faujan, N.
collection PubMed
description The aim of this study was to determine the changes of short chain fatty acids (SCFAs) in faeces of inflammatory bowel disease (IBD) patients compared to healthy subjects. SCFAs such as pyruvic, lactic, formic, acetic, propionic, isobutyric and butyric acids were analyzed by using high performance liquid chromatography (HPLC). This study showed that the level of acetic, 162.0 µmol/g wet faeces, butyric, 86.9 µmol/g wet faeces, and propionic acids, 65.6 µmol/g wet faeces, decreased remarkably in IBD faecal samples when compared with that of healthy individuals, 209.7, 176.0, and 93.3 µmol/g wet faeces respectively. On the contrary, lactic and pyruvic acids showed higher levels in faecal samples of IBD than in healthy subjects. In the context of butyric acid level, this study also found that the molar ratio of butyric acid was higher than propionic acid in both faecal samples. This might be due to the high intake of starch from rice among Malaysian population. It was concluded that the level of SCFAs differ remarkably between faecal samples in healthy subjects and that in IBD patients providing evidence that SCFAs more likely play an important role in the pathogenesis of IBD.
format Text
id pubmed-2887640
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Bentham Open
record_format MEDLINE/PubMed
spelling pubmed-28876402010-06-18 The Impact of the Level of the Intestinal Short Chain Fatty Acids in Inflammatory Bowel Disease Patients Versus Healthy Subjects Huda-Faujan, N. Abdulamir, A.S. Fatimah, A.B. Anas, O. Muhammad Shuhaimi, M. Yazid, A.M. Loong, Y.Y. Open Biochem J Article The aim of this study was to determine the changes of short chain fatty acids (SCFAs) in faeces of inflammatory bowel disease (IBD) patients compared to healthy subjects. SCFAs such as pyruvic, lactic, formic, acetic, propionic, isobutyric and butyric acids were analyzed by using high performance liquid chromatography (HPLC). This study showed that the level of acetic, 162.0 µmol/g wet faeces, butyric, 86.9 µmol/g wet faeces, and propionic acids, 65.6 µmol/g wet faeces, decreased remarkably in IBD faecal samples when compared with that of healthy individuals, 209.7, 176.0, and 93.3 µmol/g wet faeces respectively. On the contrary, lactic and pyruvic acids showed higher levels in faecal samples of IBD than in healthy subjects. In the context of butyric acid level, this study also found that the molar ratio of butyric acid was higher than propionic acid in both faecal samples. This might be due to the high intake of starch from rice among Malaysian population. It was concluded that the level of SCFAs differ remarkably between faecal samples in healthy subjects and that in IBD patients providing evidence that SCFAs more likely play an important role in the pathogenesis of IBD. Bentham Open 2010-05-13 /pmc/articles/PMC2887640/ /pubmed/20563285 http://dx.doi.org/10.2174/1874091X01004010053 Text en © Huda-Faujan et al.; Licensee Bentham Open. http://creativecommons.org/licenses/by-nc/3.0/ This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
spellingShingle Article
Huda-Faujan, N.
Abdulamir, A.S.
Fatimah, A.B.
Anas, O. Muhammad
Shuhaimi, M.
Yazid, A.M.
Loong, Y.Y.
The Impact of the Level of the Intestinal Short Chain Fatty Acids in Inflammatory Bowel Disease Patients Versus Healthy Subjects
title The Impact of the Level of the Intestinal Short Chain Fatty Acids in Inflammatory Bowel Disease Patients Versus Healthy Subjects
title_full The Impact of the Level of the Intestinal Short Chain Fatty Acids in Inflammatory Bowel Disease Patients Versus Healthy Subjects
title_fullStr The Impact of the Level of the Intestinal Short Chain Fatty Acids in Inflammatory Bowel Disease Patients Versus Healthy Subjects
title_full_unstemmed The Impact of the Level of the Intestinal Short Chain Fatty Acids in Inflammatory Bowel Disease Patients Versus Healthy Subjects
title_short The Impact of the Level of the Intestinal Short Chain Fatty Acids in Inflammatory Bowel Disease Patients Versus Healthy Subjects
title_sort impact of the level of the intestinal short chain fatty acids in inflammatory bowel disease patients versus healthy subjects
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2887640/
https://www.ncbi.nlm.nih.gov/pubmed/20563285
http://dx.doi.org/10.2174/1874091X01004010053
work_keys_str_mv AT hudafaujann theimpactoftheleveloftheintestinalshortchainfattyacidsininflammatoryboweldiseasepatientsversushealthysubjects
AT abdulamiras theimpactoftheleveloftheintestinalshortchainfattyacidsininflammatoryboweldiseasepatientsversushealthysubjects
AT fatimahab theimpactoftheleveloftheintestinalshortchainfattyacidsininflammatoryboweldiseasepatientsversushealthysubjects
AT anasomuhammad theimpactoftheleveloftheintestinalshortchainfattyacidsininflammatoryboweldiseasepatientsversushealthysubjects
AT shuhaimim theimpactoftheleveloftheintestinalshortchainfattyacidsininflammatoryboweldiseasepatientsversushealthysubjects
AT yazidam theimpactoftheleveloftheintestinalshortchainfattyacidsininflammatoryboweldiseasepatientsversushealthysubjects
AT loongyy theimpactoftheleveloftheintestinalshortchainfattyacidsininflammatoryboweldiseasepatientsversushealthysubjects
AT hudafaujann impactoftheleveloftheintestinalshortchainfattyacidsininflammatoryboweldiseasepatientsversushealthysubjects
AT abdulamiras impactoftheleveloftheintestinalshortchainfattyacidsininflammatoryboweldiseasepatientsversushealthysubjects
AT fatimahab impactoftheleveloftheintestinalshortchainfattyacidsininflammatoryboweldiseasepatientsversushealthysubjects
AT anasomuhammad impactoftheleveloftheintestinalshortchainfattyacidsininflammatoryboweldiseasepatientsversushealthysubjects
AT shuhaimim impactoftheleveloftheintestinalshortchainfattyacidsininflammatoryboweldiseasepatientsversushealthysubjects
AT yazidam impactoftheleveloftheintestinalshortchainfattyacidsininflammatoryboweldiseasepatientsversushealthysubjects
AT loongyy impactoftheleveloftheintestinalshortchainfattyacidsininflammatoryboweldiseasepatientsversushealthysubjects